Stryker is examining a bid for UK medical-device manufacturer Smith & Nephew, said a Bloomberg report citing sources familiar with the matter.» Read More
"Do as I do, not as I say" That’s, the motto behind a little segment we like to call whale watching where we profile the world's most successful investors - a.k.a whales - and try to find out if you can trade in their wake.
Tuesday's explosive stock rally, fueled by the Fed's latest efforts to stem the credit crisis, is convincing more on Wall Street that the market may finally be nearing a bottom.
But not just for the environment. There’s a bull market here that investors shouldn’t miss.
Enthusiasm for the Federal Reserve's actions to stem the credit crunch propelled the Dow Jones Industrial Average to a higher close Monday, a day when everyone expected a rout due to weekend fire sale of Bear Stearns.
The Dow Jones Industrial Average pared its losses Monday as the sell-off spurred by the fire sale of Bear Stearns wasn't as bad as expected.
Q: On Fast Money’s trader radar we look at the stock that was lighting up screens across Wall Street. The current market is giving many investors headaches and as they reach for Tylenol, its maker may be the band-aid their portfolio needs. The largest health products company sells everything from Listerine mouthwash to artificial sweeteners and the stock popped today after FDA approved its new stents. Who is it?
Stocks plunged at the opening bell Monday as investors were spooked by the cash crisis at Bear Stearns that forced its sale for $2 a share to JP Morgan Chase.
Dow Industrials newcomer Bank of America leads the list as the highest current yielder of all 30 Dow stocks. Chevron, the other recent Dow addition enters the list with a 2.7% yield.
Scientists advising the Food and Drug Administration said anemia drugs sold by Amgen and Johnson & Johnson should be allowed to stay on the market for chemotherapy patients.
Stocks closed higher Thursday after Standard & Poor's delivered the words Wall Street was waiting to hear: The end is in sight.
Amgen, the world's biggest biotech company in terms of sales (Genentech dwarfs Amgen in market cap: $86 billion vs. $51 billion) and Dow component Johnson & Johnson avoided a worst-case scenario this afternoon.
Ahead of the big FDA Advisory Committee meeting tomorrow, Amgen held a quick conference call with some reporters this afternoon. The outside panel of experts will be deciding whether to recommend putting more restrictions on the use of the blockbuster drugs used to fight anemia in cancer patients getting chemo. For Johnson and Johnson and especially Amgen, the stakes are high.
Shares of biotech giant Amgen fell as low as $43.14 (a new bottom) this morning after the briefing documents for Thursday's Food and Drug Administration Advisory Committee meeting were posted on the agency's website.
This is a big week for the world's top-two biotechnology companies and their investors. What’s going on and how can you trade it?
Billionaire Alfred Mann must not have liked watching stock in the company bearing his name fall to another new low today in the wake of Eli Lilly giving up on inhaled insulin.
This is a big week for the world's top-two biotechnology companies and their investors. Amgen goes before an FDA Advisory Committee Thursday about the side effects of its bread-and-butter franchise Aranesp.
Forbes just released its annual list of the world's wealthiest individuals, with Warren Buffett climbing to the number one spot. Here is the list of largest companies by Market Cap on the S&P 500.
With Warren Buffett nosing around Big Pharma, investors are starting to wonder if drug makers might be the remedy to what ails this market.
On the eve of the make-or-break Texas-Ohio primaries for Sen. Hillary Clinton, she remains in first place in at least one "poll." The Center for Responsive Politics has updated its list of top pharmaceuticals/health products-industry money recipients based on the most recent campaign finance reports and the former First Lady edges out Sen. Barack Obama...
What's the trade as a new breed of retirees begin their Miami migration?